National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic:

Joel M Gelfand1, April W Armstrong2, Stacie Bell3

  • 1Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania; Department of Biostatistics, Epidemiology and Informatics and the Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Insights

This guidance offers recommendations for managing psoriatic disease during the COVID-19 pandemic, covering treatment impacts, risk reduction, and care optimization for patients with psoriasis and psoriatic arthritis.

Area of Science:

  • Immunodermatology
  • Rheumatology
  • Infectious Diseases
  • Public Health

Background:

  • Psoriatic disease management presents unique challenges during pandemics.
  • The coronavirus disease 2019 (COVID-19) pandemic necessitates updated clinical guidance for chronic conditions.
  • Patients with psoriatic disease may have altered risks and require specific care considerations.

Purpose of the Study:

  • To develop evidence-based guidance for managing psoriatic disease during the COVID-19 pandemic.
  • To address clinical questions regarding COVID-19 risk, outcomes, and treatment optimization for patients with psoriatic disease.
  • To provide actionable recommendations for healthcare providers and patients.

Main Methods:

  • A multidisciplinary task force (TF) with expertise in dermatology, rheumatology, and infectious diseases was convened.
  • A Delphi process was employed to reach consensus on clinical guidance statements.
  • Clinical questions were informed by inquiries from the National Psoriasis Foundation (NPF) community.

Main Results:

  • Twenty-two guidance statements were approved by the TF.
  • All statements achieved agreement, with 9 receiving high consensus and 13 moderate consensus.
  • Recommendations cover COVID-19 risk, treatment implications, and patient care strategies.

Conclusions:

  • The developed guidance addresses critical aspects of psoriatic disease management during the COVID-19 pandemic.
  • Evidence quality for some recommendations is limited, highlighting the need for ongoing research.
  • The guidance is intended as a living document, subject to updates as new data emerge.
Abstract

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...